Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study

Objectives: We aimed to evaluate the drug retention rate and safety of secukinumab (SEC) in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) in a real clinical setting. Methods: This multicenter retrospective observational study included all AxSpA and PsA patients who rece...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Med (Lausanne)
Asıl Yazarlar: Alonso, Sara, Villa, Ignacio, Fernández, Sabela, Martín, José L., Charca, Lilyan, Pino, Marina, Riancho, Leyre, Morante, Isla, Santos, Monserrat, Brandy, Anahy, Aurrecoechea, Elena, Carmona, Loreto, Queiro, Rubén
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8187784/
https://ncbi.nlm.nih.gov/pubmed/34124110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.679009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller